Home > Insider Trading > Filing (0000950170-25-077934)

Filing Details

Accession Number:: 0000950170-25-077934
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-05-27 18:37:36
Reporting Period:: 2025-05-23

Filing Date:: 2025-05-27
Accepted Time:: 2025-05-27 18:37:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1673743	Hinge Health Inc.	HNGE	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1305473	Insight Holdings Group, Llc	C/O Insight Partners 1114 Avenue Of The Americas, 36Th Floor New York NY 10036	No	No	No	No
1710834	Insight Venture Partners X (Co-Investors), L.p.	C/O Insight Partners 1114 Avenue Of The Americas, 36Th Floor New York NY 10036	No	No	No	No
1710835	Insight Venture Partners (Delaware) X, L.p.	C/O Insight Partners 1114 Avenue Of The Americas, 36Th Floor New York NY 10036	No	No	No	No
1710860	Insight Venture Partners (Cayman) X, L.p.	C/O Insight Partners 1114 Avenue Of The Americas, 36Th Floor New York NY 10036	No	No	No	No
1710959	Insight Venture Partners X, L.p.	C/O Insight Partners 1114 Avenue Of The Americas, 36Th Floor New York NY 10036	No	No	No	No
1803240	Insight Venture Associates X, Ltd.	C/O Insight Partners 1114 Avenue Of The Americas, 36Th Floor New York NY 10036	No	No	No	No
1844845	Insight Venture Associates X, L.p.	C/O Insight Partners 1114 Avenue Of The Americas, 36Th Floor New York NY 10036	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2025-05-23	1,250,000	$0.00	1,250,000	No	4	C	Indirect	See footnotes
Class A Common Stock	Disposition	2025-05-23	1,250,000	$32.00	0	No	4	S	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnotes
No	4	S	Indirect	See footnotes

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class B Common Stock	Series B Preferred Stock	Disposition	2025-05-23	8,982,183	$0.00	8,982,183	$0.00
Class B Common Stock	Series C Preferred Stock	Disposition	2025-05-23	2,026,592	$0.00	2,026,592	$0.00
Class B Common Stock	Series C-1 Preferred Stock	Disposition	2025-05-23	451,723	$0.00	451,723	$0.00
Class B Common Stock	Series D Preferred Stock	Disposition	2025-05-23	819,106	$0.00	819,106	$0.00
Class A Common Stock	Class B Common Stock	Acquisiton	2025-05-23	12,279,604	$0.00	12,279,604	$0.00
Class A Common Stock	Class B Common Stock	Disposition	2025-05-23	1,250,000	$0.00	1,250,000	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	No	4	J	Indirect
0	No	4	J	Indirect
0	No	4	J	Indirect
0	No	4	J	Indirect
12,279,604	No	4	J	Indirect
11,029,604	No	4	C	Indirect

Footnotes

Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation.
Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities.
Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein.
Consists of (i) 624,242 shares of Class B Common Stock held by IVP X were converted into 624,242 shares of Class A Common Stock, (ii) 511,886 shares of Class B Common Stock held by IVP Cayman X were converted into 511,886 shares of Class A Common Stock, (iii) 99,019 shares of Class B Common Stock held by IVP Delaware X were converted into 99,019 shares of Class A Common Stock, and (iv) 14,853 shares of Class B Common Stock held by IVP X Co-Investors were converted into 14,853 shares of Class A Common Stock, and such shares of Class A Common Stock were sold in connection with the Issuer's initial public offering.
Consists of (i) 6,132,355 shares held by IVP X, (ii) 5,028,605 shares held by IVP Cayman X, (iii) 972,734 shares held by IVP Delaware X, and (iv) 145,910 shares held by IVP X Co-Investors.
Following the transactions reported in this Form 4, (i) 5,508,113 shares of Class B Common Stock are held by IVP X, (ii) 4,516,719 shares of Class B Common Stock are held by IVP Cayman X, (iii) 873,715 shares of Class B Common Stock are held by IVP Delaware X, and (iv) 131,057 shares of Class B Common Stock are held by IVP X Co-Investors.